| Patents for A61P 23 - Anaesthetics (4,141) |
|---|
| 04/17/2003 | WO2003030862A2 Anaesthetic compositions and method for their administration |
| 04/17/2003 | WO2003007875A3 Compounds with analgesic, antipyretic and/or anti-inflammatory activity |
| 04/17/2003 | WO2002089770A3 Topical lamellar double membrane structure composition containing n-acyl-ethanolamine and/or a quaternary ammonium salt and/or adenosylmethionine |
| 04/17/2003 | WO2002024181A3 The use of melatonin for induction of general anesthesia |
| 04/17/2003 | WO2002017881A3 Transdermal pharmaceutical delivery composition |
| 04/17/2003 | US20030073724 Central nervous system disorders |
| 04/17/2003 | CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/16/2003 | EP1302201A1 Pharmaceutical composition improved in peroral absorbability |
| 04/16/2003 | EP0904055B1 Buccal, non-polar spray or capsule |
| 04/16/2003 | CN1411440A Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 04/15/2003 | US6548507 Use of sodium channel antagonists in the treatment of diseases mediated or exacerbated by neuronal apoptosis, such as multiple sclerosis; administering drugs such as lamotrigine |
| 04/10/2003 | WO2002083108A3 Compositions containing cgmp pde inhibitors and local anaesthetic agents for nasal application |
| 04/10/2003 | US20030069292 Central nervous system disorders; anticonvulsants |
| 04/10/2003 | US20030069288 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 04/10/2003 | US20030069263 Prevention drug abruse; analgesics |
| 04/10/2003 | US20030069249 Analgesics; central nervous system disorders |
| 04/10/2003 | US20030069241 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents |
| 04/09/2003 | EP1300141A1 Medical composition kit for treating lesioned abnormal tissue |
| 04/09/2003 | EP1299287A1 Methods of producing a terminally sterilized topical patch preparation |
| 04/09/2003 | EP1299095A1 Clear aqueous anaesthetic composition |
| 04/09/2003 | EP0724439B1 Use of 2-(2alkylphenylamino)oxazolines and -thiazolines for the manufacture of a medicament with alpha 2 adrenergic effect |
| 04/09/2003 | CN1104901C Medicinal preparation containing lipophilicity inert gas |
| 04/03/2003 | WO2003026632A2 Substituted phenol compounds useful for anesthesia and sedation |
| 04/03/2003 | WO2003026479A2 Methods of suppressing microglial activation |
| 04/03/2003 | WO2002007743A3 Piper methysticum plant extract |
| 04/03/2003 | US20030064961 Anaesthetic composition |
| 04/03/2003 | US20030062042 Aerosol generating method and device |
| 04/03/2003 | CA2461305A1 Methods of suppressing microglial activation and systemic inflammatory responses |
| 04/03/2003 | CA2459125A1 Substituted phenol compounds useful for anesthesia and sedation |
| 04/02/2003 | EP1297138A2 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof |
| 04/02/2003 | EP1296650A2 Methods and compositions for treating pain of the mucous membrane |
| 03/26/2003 | EP1294659A2 Process for isolating enantiomers of racemic cetamine |
| 03/26/2003 | EP1294364A1 Stable gabapentin having ph within a controlled range |
| 03/26/2003 | EP1126848B1 Plastics container containing stabilised drug formulations |
| 03/20/2003 | WO2003022285A1 Heterocyclic substituted 2- (4-phenoxy) pyridine derivatives and related compounds as sodium channel blockers for the treatment of neuronal damage and neurodegenerative conditions |
| 03/20/2003 | WO2003022276A1 Aryl substituted pyridinecarboxamides and their use as sodium channel blockers |
| 03/20/2003 | US20030055109 Stability |
| 03/20/2003 | US20030055088 Aryl substituted pyridines and the use thereof |
| 03/20/2003 | US20030055055 For inducing and maintaining anesthesia, sedation and muscle relaxation, as well as for combating febrile convulsions in children |
| 03/20/2003 | US20030055023 Injectable formulation of a sedative hypnotic drug, such as the anesthetic drug etomidate, that is pharmaceutically stable, demonstrates a reduced incidence of pain upon injection |
| 03/20/2003 | US20030054017 Alcohol based topical anesthetic formulation and method |
| 03/20/2003 | US20030051728 Method and device for delivering a physiologically active compound |
| 03/20/2003 | CA2459531A1 Heterocyclic substituted 2- (4-phenoxy) pyridine derivatives and related compounds as sodium channel blockers for the treatment of neuronal damage and neurodegenerative conditions |
| 03/20/2003 | CA2459527A1 Aryl substituted pyridinecarboxamides and their use as sodium channel blockers |
| 03/19/2003 | EP1293203A1 Alcohol based local anaesthetic formulation |
| 03/19/2003 | EP1292577A2 Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker |
| 03/19/2003 | EP1292282A2 Improved injectable dispersions of propofol |
| 03/18/2003 | US6534081 Administration of microparticles in a form suitable for injection and containing active agents suitable for treating or diagonising a disease or painful condition in joints in a patient in need, safe and effective procedure; sustained |
| 03/13/2003 | WO2003020037A1 Multivesicular emulsion topical delivery systems |
| 03/13/2003 | US20030050234 Conotoxin peptide extracted from the venom of a marine snail, Conus magnus (cono=cone); disorders associated with voltage gated sodium ion channel; neuromuscular blocking agents; local anesthetics; neuroprotective agents; analgesics |
| 03/13/2003 | US20030049281 Topical emulsion; quaternary ammonium salt emulsifier |
| 03/12/2003 | EP1291039A1 Use of a mixture of lidocaine and prilocaine and composition for tumescent local anesthesia |
| 03/12/2003 | EP1289503A2 O/w emulsion |
| 03/06/2003 | WO2003017977A1 Anaesthetic formulations of propofol |
| 03/06/2003 | WO2002074200B1 Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
| 03/06/2003 | US20030044446 A multilayered film comprising a first, water-soluble adhesive layer to be placed in contact with a mucosal surface and a second, water-erodible non-adhesive backing layer that controls residence time; drug delivery from mouth |
| 03/05/2003 | EP1287134A2 The human voltage-gated sodium channel beta-1a subunit and methods of use |
| 03/05/2003 | EP1286986A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 03/04/2003 | US6528086 Methods and apparatus for drug delivery involving phase changing formulations |
| 02/27/2003 | WO2003015748A2 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 02/27/2003 | WO2003015699A2 Topical compositions and methods for treating pain |
| 02/27/2003 | US20030040513 P2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 02/27/2003 | US20030040044 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/27/2003 | CA2459692A1 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 02/26/2003 | EP1285657A2 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 02/20/2003 | WO2003014124A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 02/20/2003 | WO2003013530A2 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives as nmda antagonists |
| 02/20/2003 | WO2003013475A1 Injectable foam and novel pharmaceutical applications thereof |
| 02/20/2003 | WO2002098390A3 Delivery of aerosols containing small particles through an inhalation route |
| 02/20/2003 | US20030036552 Novel compounds |
| 02/20/2003 | US20030035776 Drug particle in aerosol |
| 02/20/2003 | CA2456124A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 02/20/2003 | CA2456103A1 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 02/19/2003 | EP1284151A1 Topical treatment of pain and to promote healing including capsaicin as an analgesic |
| 02/18/2003 | US6521621 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 02/13/2003 | WO2003011262A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes |
| 02/13/2003 | CA2454414A1 Use of 2-alkoxyphenyl-substituted imidazotriazinones |
| 02/12/2003 | CN1396830A Pharmaceutical parenteral composition containing biphosphonate |
| 02/08/2003 | CA2354932A1 Topical treatment of pain and to promote healing |
| 02/06/2003 | WO2003010168A1 4-oxoimidazolidine-2-spiropiperidine derivative |
| 02/06/2003 | US20030027835 Trimebutine, N-desmethyltrimebutine, their metabolites or their stereoisomers and an opioid analgesic for treating pain or nociception. |
| 02/05/2003 | EP1280531A1 Local anesthetic methods and kits |
| 02/05/2003 | CN1394853A Levobubikain carbonate and its preparation |
| 02/05/2003 | CN1394595A Dicaine foaming compound anesthetic |
| 02/04/2003 | US6514994 Levobupivacaine and its use |
| 02/04/2003 | CA2268967C Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics |
| 01/30/2003 | WO2003008398A1 Aryl substituted thiazolidinones and the use thereof |
| 01/30/2003 | WO2003008370A1 Substituted 4-aminocyclohexanols |
| 01/30/2003 | WO2003007990A1 Myosin agonist |
| 01/30/2003 | WO2003007875A2 Compounds with analgesic, antipyretic and/or anti-inflammatory activity |
| 01/30/2003 | WO2003007802A2 Pharmaceutical combinations of oxycodone and naloxone |
| 01/30/2003 | US20030022894 Imidazotriazinone-containing compositions for nasal administration |
| 01/30/2003 | CA2453633A1 Aryl substituted thiazolidinones and the use thereof |
| 01/29/2003 | EP1279666A1 1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands |
| 01/29/2003 | EP1279406A1 Transporters and drug delivery system by using the same |
| 01/29/2003 | EP0817772B1 Pyrrolidinyl hydroxamic acid compounds and their production process |
| 01/24/2003 | CA2394209A1 1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands |
| 01/23/2003 | US20030018041 Spiroindene and spiroindane compounds |
| 01/23/2003 | US20030017527 Human vanilloid receptor-like proteins |
| 01/23/2003 | US20030015197 Method of forming an aerosol for inhalation delivery |